Market Overview:
The global pets pain relief and prevention market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing awareness about pet health and rising demand for pain relief products for pets. Based on type, the global pets pain relief and prevention market is segmented into external use and internal use. External use dominates the global market, owing to its easy availability and low cost as compared to internal use products. Based on application, the global pets pain relief and prevention market is segmented into dogs, cats, other animals (pigs, horses etc.). Dogs account for a major share of the overall application segment due to their high vulnerability towards various types of injuries and diseases. Geographically, North America dominates the global Pets Pain Relief And Prevention Market followed by Europe due To Increasing Adoption Of Pets In These Regions And Rising Prevalence Of Pet Diseases Such As Arthritis And Cancer.
Product Definition:
Pets Pain Relief and Prevention is an important field in veterinary medicine. It refers to the use of various medications, therapies, and techniques to reduce or prevent pain in pets. This can be important for a number of reasons, including improving the quality of life for animals that are suffering from pain and helping them to recover more quickly from surgery or other procedures.
External Use:
External Use is a new term in the field of pet care and it has been used for only a few decades. It is defined as procedures or drugs that are given to pets outside of veterinary medicine. In other words, these are medications that can be given to animals for human health conditions like arthritis, diabetes or cancer but cannot be diagnosed through clinical signs in animals.
The external use market was estimated at USD 1 billion in 2015.
Internal Use:
The internal use and it’s usage in pets pain relief and prevention market is expected to grow at a significant rate over the forecast period. The factors that propel the growth of this market include increasing pet population, rising disposable income, technological advancements in pharmaceutical industry for pet health. Moreover, growing awareness among owners regarding their pet’s health problems also boosts demand for various treatment options such as pain management solutions.
Internal use & it's usage in pets pain relief.
Application Insights:
In 2017, the dogs segment dominated the market for pet pain relief and prevention with a revenue share of over 60%. The rising number of dog ownership is one of the major factors contributing to this growth. According to a blog by Statista, in 2018, there are nearly 78 million households in America having at least one dog. Moreover, according to American Pet Products Association (APPA), more than 56 million cats were adopted in U.S from 2008-2017. These factors indicate that majority of pet owners prefer adopting animals from shelters or rescue organizations which results in high adoption rates for pets like dogs and cats across various regions worldwide. This trend is expected to continue over the forecast period as people are becoming more aware about their companion's health and well being owing to increasing humanization trends across various countries worldwide including China India Brazil Japan Mexico Argentina etc.
The other segment includes fish tanks etc., reptiles such as snakes & turtles etc., birds such as parrots & cockatoos etc.
Regional Analysis:
North America dominated the global pets pain relief and prevention market in 2017. This can be attributed to factors such as high pet ownership, better veterinary healthcare facilities, and higher expenditure on animal care. According to a study published by the American Pet Products Association (APPA), approximately 68% of U.S households owned at least one dog while 58% owned cats in 2016. Moreover, according to APPA survey, about 80 million U.
Asia Pacific is expected to witness lucrative growth over the forecast period owing its increasing number of pet population coupled with rising disposable income especially in developing countries like India and China which will drive demand for various types of pets including exotic animals such as lions.
Growth Factors:
- Increasing pet ownership: The global pet population is expected to grow at a CAGR of 3.8% from 2019 to 2025, reaching 887 million by 2025. This growth in the pet population will lead to an increase in demand for pain relief and prevention products for pets.
- Rising awareness about animal health and wellness: There is a growing awareness among consumers about the importance of animal health and wellness, which is driving demand for better quality pain relief and prevention products for pets.
- Growing trend of holistic pet care: A growing number of consumers are opting for holistic pet care, which includes using natural ingredients and remedies to treat their pets’ ailments. This is leading to an increase in demand for organic pain relief and prevention products for pets.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pets Pain Relief and Prevention Market Research Report
By Type
External Use, Internal Use
By Application
Dogs, Cats, Other
By Companies
Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Pets Pain Relief and Prevention Market Report Segments:
The global Pets Pain Relief and Prevention market is segmented on the basis of:
Types
External Use, Internal Use
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dogs, Cats, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim
- Zoetis
- Merck
- Elanco
- Bayer
- Virbac
- Ceva Sante Animale
- Vetoquinol
- Bimeda Animal Health
- Chanelle
Highlights of The Pets Pain Relief and Prevention Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- External Use
- Internal Use
- By Application:
- Dogs
- Cats
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pets Pain Relief and Prevention Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pets Pain Relief and Prevention is a website that provides information on how to reduce the pain and suffering of pets. The site includes articles, tips, and resources on topics such as pet health care, nutrition, exercise, behavior modification techniques, and more.
Some of the major players in the pets pain relief and prevention market are Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle.
The pets pain relief and prevention market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pets Pain Relief and Prevention Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pets Pain Relief and Prevention Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pets Pain Relief and Prevention Market - Supply Chain
4.5. Global Pets Pain Relief and Prevention Market Forecast
4.5.1. Pets Pain Relief and Prevention Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pets Pain Relief and Prevention Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pets Pain Relief and Prevention Market Absolute $ Opportunity
5. Global Pets Pain Relief and Prevention Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pets Pain Relief and Prevention Market Size and Volume Forecast by Type
5.3.1. External Use
5.3.2. Internal Use
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pets Pain Relief and Prevention Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pets Pain Relief and Prevention Market Size and Volume Forecast by Application
6.3.1. Dogs
6.3.2. Cats
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pets Pain Relief and Prevention Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pets Pain Relief and Prevention Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pets Pain Relief and Prevention Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pets Pain Relief and Prevention Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pets Pain Relief and Prevention Demand Share Forecast, 2019-2026
9. North America Pets Pain Relief and Prevention Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pets Pain Relief and Prevention Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pets Pain Relief and Prevention Market Size and Volume Forecast by Application
9.4.1. Dogs
9.4.2. Cats
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pets Pain Relief and Prevention Market Size and Volume Forecast by Type
9.7.1. External Use
9.7.2. Internal Use
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pets Pain Relief and Prevention Demand Share Forecast, 2019-2026
10. Latin America Pets Pain Relief and Prevention Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pets Pain Relief and Prevention Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pets Pain Relief and Prevention Market Size and Volume Forecast by Application
10.4.1. Dogs
10.4.2. Cats
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pets Pain Relief and Prevention Market Size and Volume Forecast by Type
10.7.1. External Use
10.7.2. Internal Use
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pets Pain Relief and Prevention Demand Share Forecast, 2019-2026
11. Europe Pets Pain Relief and Prevention Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pets Pain Relief and Prevention Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pets Pain Relief and Prevention Market Size and Volume Forecast by Application
11.4.1. Dogs
11.4.2. Cats
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pets Pain Relief and Prevention Market Size and Volume Forecast by Type
11.7.1. External Use
11.7.2. Internal Use
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pets Pain Relief and Prevention Demand Share, 2019-2026
12. Asia Pacific Pets Pain Relief and Prevention Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pets Pain Relief and Prevention Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pets Pain Relief and Prevention Market Size and Volume Forecast by Application
12.4.1. Dogs
12.4.2. Cats
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pets Pain Relief and Prevention Market Size and Volume Forecast by Type
12.7.1. External Use
12.7.2. Internal Use
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pets Pain Relief and Prevention Demand Share, 2019-2026
13. Middle East & Africa Pets Pain Relief and Prevention Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pets Pain Relief and Prevention Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pets Pain Relief and Prevention Market Size and Volume Forecast by Application
13.4.1. Dogs
13.4.2. Cats
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pets Pain Relief and Prevention Market Size and Volume Forecast by Type
13.7.1. External Use
13.7.2. Internal Use
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pets Pain Relief and Prevention Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pets Pain Relief and Prevention Market: Market Share Analysis
14.2. Pets Pain Relief and Prevention Distributors and Customers
14.3. Pets Pain Relief and Prevention Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Boehringer Ingelheim
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zoetis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Elanco
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bayer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Virbac
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ceva Sante Animale
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Vetoquinol
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Bimeda Animal Health
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Chanelle
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook